Hematology

Cards (205)

  • Hematopoiesis
    The process of blood cell formation
  • Erythropoietin (EPO)
    • Synthesized from peritubular interstitial fibroblast (cortex and outer medulla)
  • Supravital stains for reticulocyte identification
    New methylene blue/Brilliant cresyl blue
  • Anemia
    Hb < 13 g/dL (male), Hb < 12 g/dL (female), Hb < 11 g/dL (pregnancy), Hb < 10 g/dL (CKD)
  • Reticulocyte count
    Measured in %, Corrected retic count = Retic count x (Hb of the patient/desired Hb)
  • Needs evaluation: Hb > 16.5 g/dL (male), Hb > 16 g/dL (female)
  • Blood cells formed from hematopoietic stem cells
    • RBC
    • Platelet
    • Neutrophil
    • Eosinophil
    • Basophil
    • Monocyte → Macrophage (tissues)
    • B Lymphocytes
    • T Lymphocytes
    • NK Cells
  • Desired Hb: 15 g/dL (male), 13 g/dL (female)
  • Reticulocyte Production Index (RPI)
    Best indicator of bone marrow response
  • Mean Corpuscular Volume (MCV)
    Average volume of an RBC, Normal range: 80 - 100 fL
  • Hypoproliferative anemia
    • Symptoms duration: 2-3 months, RPI < 2.5, MCV normal to low
  • Causes of hypoproliferative anemia
    • Iron deficiency anemia
    • Megaloblastic anemia (vitamin B12, folate deficiency)
    • Non megaloblastic macrocytic anemia
    • Anemia of chronic disease
    • Sideroblastic anemia
    • Thalassemia trait/thalassemia minor
  • Hypoproliferative anemia
    RPI < 2.5
  • Hyperproliferative anemia
    RPI > 2.5
  • RPI
    Corrected Retic count/2
  • Macrocytosis
    MCV > 100
  • Types of macrocytic anemia
    • Megaloblastic
    • Non megaloblastic
  • RPI < 2.5
    Normal/decreased MCV
  • Increased MCV
    Macrocytosis
  • Causes of macrocytic anemia with RPI < 2.5
    • Iron deficiency anemia
    • Anemia of chronic disease
    • Sideroblastic anemia
    • Thalassemia trait
  • Heme iron
    Fe2+ state, Transported via heme transporter
  • Non-heme iron
    Fe3+ state, Transported via Divalent Metal Transporter (DMT-1)
  • 2/3rd of dietary iron is heme iron, 1/3rd is non-heme iron
  • Iron stores detection
    Prussian blue (mainly hemosiderin)
  • Iron stores in the body
    • Bone marrow
    • Macrophage
    • Liver
    • Brain
    • Duodenal enterocytes
  • Iron indices
    • Serum ferritin
    • Serum iron
    • TIBC (Total iron binding capacity)
    • TSAT (Transferrin Saturation)
  • Serum ferritin
    Reflects iron stores in the body, Earliest marker of Fe deficiency anemia, High S. ferritin (acute phase reactant) cannot rule out Fe deficiency
  • Serum iron
    Amount of transferrin bound Fe in circulation
  • TIBC
    Indirect measurement of S. Transferrin
  • TSAT
    TSAT = (S. Fe/TIBC) x 100, Around 33% or 1/3rd of TIBC
  • Iron stored inside the cell
    Fe3+ state, Ferritin (major), Hemosiderin (minor: Macrophages)
  • Iron transport
    1. Iron in Fe2+ state transported out via ferroportin
    2. Hephaestin in basolateral membrane converts Fe2+ → Fe3+
    3. Fe3+ binds to transferrin (transport form)
    4. Fe3+-transferrin complex
    5. Marrow → Soluble transferrin receptors: Bind Fe-transferrin complex
    6. Transferrin released into circulation
    7. Fe3+ taken up for erythropoiesis
  • In brain, conversion of Fe2+ → Fe3+ is done by ceruloplasmin
  • Earliest marker of Fe deficiency: S. Ferritin, Most specific & sensitive marker: Soluble Transferrin Receptor assay (STFR) or log ferritin
  • Free erythrocyte protoporphyrin: Lack of Fe to bind to protoporphyrin
  • Clinical features of iron deficiency anemia
    • Fatigue
    • Tiredness
    • Palpitation
    • Pallor on examination
    • PICA symptoms (especially pagophagia)
    • Restless leg syndrome
    • Epithelial changes (nails, tongue, mouth, hypopharynx, stomach)
    • Growth related issues
    • Neuropsychiatric issues in growing child
    • Hair loss
  • Anemia in males usually evaluated with colonoscopy and upper GI endoscopy to rule out GI bleed
  • Anti-Ttg ab, anti-endomysial ab used to detect celiac disease
  • EPO therapy should be started only after replenishing iron stores
  • Causes of iron deficiency anemia
    • Menstrual loss (mainly in females)
    • GI blood loss unless proved otherwise
    • Celiac disease: Malabsorption
    • CKD on erythropoietin therapy (with EPO resistance)
    • Nutritional deficiency